RAFAEL HOLDINGS, INC. Debt Securities, Available-for-sale, Realized Gain (Loss)
RAFAEL HOLDINGS, INC. (RFL) reported Debt Securities, Available-for-sale, Realized Gain (Loss) of $154.00 thousand for the 9-month period ending 2023-04-30, per its 10-Q filed 2023-06-13.
Discontinued › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss · last filed 2023-06-13
- RAFAEL HOLDINGS, INC. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2023-04-30 was $0.00.
- RAFAEL HOLDINGS, INC. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2023-01-31 was $139.00K.
- RAFAEL HOLDINGS, INC. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2022-10-31 was $15.00K.
- RAFAEL HOLDINGS, INC. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2022-07-31 was -$43.00K.
- RAFAEL HOLDINGS, INC. debt securities, available-for-sale, realized gain (loss) for fiscal 2022 was -$45.00K.
| Period end | Debt Securities, Available-for-sale, Realized Gain (Loss) 3 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 6 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 9 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2023-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-13 | $139.00K derived: sum of 2 quarters · filed 2023-06-13 | $154.00K 10-Q · filed 2023-06-13 | $111.00K derived: sum of 4 quarters · filed 2023-06-13 |
| 2023-01-31 | $139.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-14 | $154.00K 10-Q · filed 2023-03-14 | $111.00K derived: sum of 3 quarters · filed 2023-03-14 | |
| 2022-10-31 | $15.00K 10-Q · filed 2022-12-13 | -$28.00K derived: sum of 2 quarters · filed 2022-12-13 | ||
| 2022-07-31 | -$43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | -$45.00K 10-K · filed 2022-10-31 | ||
| 2022-04-30 | -$2.00K 10-Q · filed 2023-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |